| Threshold
Pharmaceuticals was founded in 2001 with the goal of improving
cancer treatment and diagnosis. Focused on building a portfolio
of anti-cancer drug products through internal research and in-licensing,
Threshold is pioneering cutting edge metabolic targeting technologies
to develop small molecules that selectively target and destroy
malignant cancer cells with minimal impact on normal cells. |
|
 |
|
|
|
|
